We examined the expression levels and clinical relevance of CHEK1, CDC25A, CCNE1, hsa‐miR‐195‐5p, and hsa‐miR‐497‐5p in a comprehensive cohort of 217 breast carcinoma patients. Here, CDC25A is linked to breast carcinoma.